As further evidenced by this settlement, the DOJ and SEC carry on to signal the challenges connected to ill-outlined pools of reimbursable distributor bills (e.g. “advertising” or “administration” charges), using free samples, rebates, and various cost concessions. The Alcon and Novartis AG DPAs can be a reminder of the necessity of control